Show simple item record

dc.contributor.authorCampain, Nicholas J
dc.contributor.authorMcGrath, John S
dc.contributor.authorAning, Jonathan
dc.date.accessioned2020-02-19T14:31:57Z
dc.date.available2020-02-19T14:31:57Z
dc.date.issued2020-01
dc.identifier.citationBlack AJ [et al]. The prognostic value of the neutrophil-to-lymphocyte ratio in patients with muscle-invasive bladder cancer treated with neoadjuvant chemotherapy and radical cystectomy. Urologic Oncology. 2020 38(1) e17-e27en_US
dc.identifier.pmid31676278
dc.identifier.doi10.1016/j.urolonc.2019.09.023
dc.identifier.urihttps://rde.dspace-express.com/handle/11287/621230
dc.description.abstractThe neutrophil-to-lymphocyte ratio (NLR) is an attractive marker because it is derived from routine bloodwork. NLR has shown promise as a prognostic factor in muscle invasive bladder cancer (MIBC) but its value in patients receiving neoadjuvant chemotherapy (NAC) before radical cystectomy (RC) is not yet established. Since NLR is related to an oncogenic environment and poor antitumor host response, we hypothesized that a high NLR would be associated with a poor response to NAC and would remain a poor prognostic indicator in patients receiving NAC.en_US
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.relation.urlhttps://linkinghub.elsevier.com/retrieve/pii/S1078-1439(19)30374-6en_US
dc.subjectWessex Classification Subject Headings::Urologyen_US
dc.titleThe prognostic value of the neutrophil-to-lymphocyte ratio in patients with muscle-invasive bladder cancer treated with neoadjuvant chemotherapy and radical cystectomyen_US
dc.typeJournal Articleen_US
dc.identifier.journalUrologic Oncologyen_US
dc.type.versionPublisheden_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record